HeartBeam Partners with Evolve Manufacturing to Build HeartBeam AIMIGoTM 12-Lead 3D Vector Electrocardiogram DeviceBusiness Wire • 12/07/22
New HeartBeam Patent for 12-Lead Electrocardiogram (ECG) Smartwatch-based Monitor Intended for Detection of Heart Attacks and Complex Cardiac ArrhythmiasBusiness Wire • 11/16/22
HeartBeam to Host Third Quarter 2022 Results Conference Call on Thursday November 10, 2022 at 4:30 p.m. Eastern TimeBusiness Wire • 10/25/22
These Were the Five Best and Worst Performing Healthcare Stocks in Q3 202224/7 Wall Street • 10/25/22
These Were The Five Best And Worst Performing Healthcare Stocks In September 202224/7 Wall Street • 10/17/22
Music NFT and SocialFi Platform, MetaBeat Attracts Investments From Top Global Crypto FundsBusiness Wire • 10/11/22
HeartBeam Broadens Product Portfolio Pipeline with Smartwatch Connectivity Enablement for 24/7 Heart Monitoring SolutionBusiness Wire • 10/06/22
HeartBeam Granted Patent for Signal Transformation from Vector Electrocardiogram (VECG) to 12-Lead Electrocardiogram (ECG)Business Wire • 09/28/22
HeartBeam Launches New Video Showcasing the HeartBeam AIMI™ and AIMIGo™ TechnologiesBusiness Wire • 09/20/22
HeartBeam Granted Patent for 12-Lead Electrocardiogram (ECG) Patch Monitor Intended for Detection of Heart Attacks and Complex Cardiac ArrhythmiasBusiness Wire • 09/15/22
HeartBeam to Host Virtual Roadshow Webinar on Tuesday September 20, 2022 at 4:30 p.m. Eastern TimeBusiness Wire • 09/12/22
HeartBeam, Inc. (BEAT) CEO Branislav Vajdic on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/12/22